Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Feb 18, 2015
Insider Transaction Report
Form 4
LICHTINGER PEDRO
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2015-02-13+200,000→ 200,000 totalExercise: $3.90Exp: 2025-02-12→ Series A Common Stock (200,000 underlying) - Award
Restricted Stock Units
2015-02-13+23,932→ 23,932 total→ Series A Common Stock (23,932 underlying)
Footnotes (3)
- [F1]These options will vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of the date of grant.
- [F2]Each restricted stock unit represents a contingent right to receive one share of AST Series A Common Stock.
- [F3]These restricted stock units vest in four equal quarterly installments beginning June 30, 2015.